These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 24034373)

  • 1. Systematic review of the efficacy and adverse events associated with infliximab treatment of hidradenitis suppurativa in patients with coexistent inflammatory diseases.
    Machet L; Samimi M; Delage M; Paintaud G; Maruani A
    J Am Acad Dermatol; 2013 Oct; 69(4):649-50. PubMed ID: 24034373
    [No Abstract]   [Full Text] [Related]  

  • 2. Diseases associated with hidranitis suppurativa: part 2 of a series on hidradenitis.
    Scheinfeld N
    Dermatol Online J; 2013 Jun; 19(6):18558. PubMed ID: 24011308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SAPHO syndrome associated with hidradenitis suppurativa successfully treated with infliximab and methotrexate.
    De Souza A; Solomon GE; Strober BE
    Bull NYU Hosp Jt Dis; 2011; 69(2):185-7. PubMed ID: 22035400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review and expert opinion on prevention and treatment of infliximab-related infusion reactions.
    Lecluse LL; Piskin G; Mekkes JR; Bos JD; de Rie MA
    Br J Dermatol; 2008 Sep; 159(3):527-36. PubMed ID: 18627374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoinflammatory syndromes associated with hidradenitis suppurativa and/or acne.
    Vinkel C; Thomsen SF
    Int J Dermatol; 2017 Aug; 56(8):811-818. PubMed ID: 28345207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infliximab for the treatment of hidradenitis suppurativa.
    Lebwohl B; Sapadin AN
    J Am Acad Dermatol; 2003 Nov; 49(5 Suppl):S275-6. PubMed ID: 14576652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there a role for infliximab in the current therapy of hidradenitis suppurativa? A report of three treated cases.
    Moschella SL
    Int J Dermatol; 2007 Dec; 46(12):1287-91. PubMed ID: 18173525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association and management of Crohn's disease plus hidradenitis suppurativa.
    dos Santos CH; Netto PO; Kawaguchi KY; Parreira Alves JA; de Alencar Souza VP; Reverdito S
    Inflamm Bowel Dis; 2012 Apr; 18(4):E801-2. PubMed ID: 21993924
    [No Abstract]   [Full Text] [Related]  

  • 9. Pyoderma gangrenosum, acne, psoriasis, arthritis and suppurative hidradenitis (PAPASH)-syndrome: a new entity within the spectrum of autoinflammatory syndromes?
    Garzorz N; Papanagiotou V; Atenhan A; Andres C; Eyerich S; Eyerich K; Ring J; Brockow K
    J Eur Acad Dermatol Venereol; 2016 Jan; 30(1):141-3. PubMed ID: 25070077
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevalence and comorbidities associated with hidradenitis suppurativa in Korea: a nationwide population-based study.
    Lee JH; Kwon HS; Jung HM; Kim GM; Bae JM
    J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1784-1790. PubMed ID: 29761904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyoderma gangrenosum treated with infliximab in inactive ulcerative colitis.
    Ermis F; Ozdil S; Akyüz F; Pinarbasi B; Mungan Z
    Inflamm Bowel Dis; 2008 Nov; 14(11):1611-3. PubMed ID: 18401859
    [No Abstract]   [Full Text] [Related]  

  • 12. Hidradenitis suppurativa and concomitant pyoderma gangrenosum treated With infliximab.
    Groleau PF; Grossberg AL; Gaspari AA
    Cutis; 2015 Jun; 95(6):337-42. PubMed ID: 26125210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrum of diseases associated with pyoderma gangrenosum and correlation with effectiveness of therapy: New insights on the diagnosis and therapy of comorbid hidradenitis suppurativa.
    Fischer AH; Jourabchi N; Khalifian S; Lazarus GS
    Wound Repair Regen; 2022 May; 30(3):338-344. PubMed ID: 35385180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of hidradenitis suppurativa and inflammatory bowel disease: are these two disease associated?
    Salgado-Boquete L; Romaní J; Carrión L; Marín-Jiménez I
    Actas Dermosifiliogr; 2016 Sep; 107 Suppl 2():8-12. PubMed ID: 28081771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of superficial pyoderma gangrenosum associated with hidradenitis suppurativa with adalimumab.
    Reddick CL; Singh MN; Chalmers RJ
    Dermatol Online J; 2010 Aug; 16(8):15. PubMed ID: 20804692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infliximab for the treatment of hidradenitis suppurativa.
    Fernández-Vozmediano JM; Armario-Hita JC
    Dermatology; 2007; 215(1):41-4. PubMed ID: 17587838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pyoderma gangrenosum associated with hidradenitis suppurativa: a case report and review of the literature].
    García-Rabasco AE; Esteve-Martínez A; Zaragoza-Ninet V; Sánchez-Carazo JL; Alegre-de-Miquel V
    Actas Dermosifiliogr; 2010 Oct; 101(8):717-21. PubMed ID: 20965015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-psoriatic dermatologic uses of monoclonal antibody therapy.
    Sockolov ME; Alikhan A; Zargari O
    J Dermatolog Treat; 2009; 20(6):319-27. PubMed ID: 19954387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Association between Hidradenitis Suppurativa and Crohn's Disease: in Search of the Missing Pathogenic Link.
    van der Zee HH; Horvath B; Jemec GBE; Prens EP
    J Invest Dermatol; 2016 Sep; 136(9):1747-1748. PubMed ID: 27542293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of hidradenitis suppurativa with infliximab in a patient with Crohn's disease.
    Rosi YL; Lowe L; Kang S
    J Dermatolog Treat; 2005 Feb; 16(1):58-61. PubMed ID: 15897171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.